Anti-OX40 Antibody PF-04518600
Anti-OX40 Antibody PF-04518600 Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-OX40 Antibody PF-04518600 is under investigation in clinical trial NCT02554812 (A Study of Avelumab in Combination With Other Cancer Immunotherapies in Advanced Malignancies (JAVELIN Medley)).
| Trade Name | Anti-OX40 Antibody PF-04518600 |
| Generic | Ivuxolimab |
| Ivuxolimab Other Names | Anti-OX40 Antibody PF-04518600, Ivuxolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-OX40 Antibody PF-04518600
